The Effect of Coenzyme Q10 in Preventing Pain After Thoracoscopic Surgery: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

This study aimed to assess the effectiveness of Coenzyme Q10 in preventing both acute and chronic pain following thoracoscopic surgery, with a focus on its potential benefits in reducing the incidence and severity of pain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Aged 18-75 years;

• American Society of Anesthesiology (ASA) physical status classification I-III;

• Scheduled for elective lung resection surgery under thoracoscopy;

• Voluntarily opting for patient-controlled intravenous analgesia;

• Willing to participate in this trial after consultation with the patient or their family and signing the informed consent form.

Locations
Other Locations
China
Guangyou Duan
RECRUITING
Chongqing
Contact Information
Primary
Guangyou Duan, ph.D
duangy@hospital.cqmu.edu.cn
(+86)18323376014
Time Frame
Start Date: 2025-01-09
Estimated Completion Date: 2026-03-20
Participants
Target number of participants: 264
Treatments
Experimental: Coenzyme Q10
Placebo_comparator: Placebo
Related Therapeutic Areas
Sponsors
Leads: The Second Affiliated Hospital of Chongqing Medical University

This content was sourced from clinicaltrials.gov